Perceptual Disorders: Clinical Trials

8 trials for Perceptual Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 terminated. 8 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 18Terminated 8
Phase 22Terminated 2

Follow Perceptual Disorders: new trials by email Literature Review of Perceptual Disorders trials Research Report on Perceptual Disorders

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Non-Opioid Pain Medications After Intracapsular Adenotonsillectomy
Oxycodone, Ibuprofen, Acetaminophen - Adenotonsillectomy, Post-operative Analgesia
Phase 1 / Phase 2TerminatedDavid Chi, MD732021-04-132024-08-30
A Single and Multiple Ascending Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of KP-1199
KP-1199, Placebo oral capsule, Oxycodone oral capsule - Analgesia
Phase 1TerminatedKalyra Pharmaceuticals, Inc.262019-03-122021-09-16
Non-opioids for Analgesia After Adenotonsillectomy in Children
Oxycodone, Ibuprofen, Acetaminophen - Adenotonsillectomy, Post-operative Analgesia
Phase 1 / Phase 2TerminatedDavid Chi, MD2682018-10-252021-11-10
A Study in Healthy Male Volunteers to Investigate the Safety and Tolerability of a Single Dose of Neosaxitoxin Alone and in Combination With Bupivacaine (With and Without Epinephrine) for Brachial Plexus Blockade
Neosaxitoxin combined with bupivacaine low and epinephrine (T1), Bupivacaine low combined with epinephrine (C1), Bupivacaine high combined with epinephrine (C2) - Anesthesia, Anesthesia, Local
Phase 1TerminatedGrĂ¼nenthal GmbH2422018-01-302018-10-11
To Evaluate the Food Effect and the Absorption Profile of Ibuprofen Controlled-Release Tablets 600 mg in Comparison to the Reference Standard Ibuprofen Tablets in Normal Healthy Volunteers
Advil Ibuprofen table 200 mg, Motrin IB Ibuprofen Tablets 200 mg, Ibuprofen CR Tablets 600 mg - Pain Control
Phase 1TerminatedOverseas Pharmaceuticals, Ltd.312017-12-112022-04-01
Efficacy of Buprenorphine on Postoperative Endodontic Analgesia
Buprenorphine, Sterile saline, lidocaine, epinephrine (Local anesthetic) - Postoperative Pain
Phase 1TerminatedUniversity Hospitals Cleveland Medical Center102017-04-012019-04-23
Effects of Local Anaesthetic Infusion Rates on Nerve Block Duration
Varying infusion rates of Ropivacaine 0.2% - Other Acute Postoperative Pain, Pain, Postoperative
Phase 1TerminatedNordsjaellands Hospital602016-10-102017-03-30
Transcranial Direct Current Stimulation (tDCS) and Task-Specific Practice for Post-stroke Neglect
tDCS, sham tDCS, Repetitive task-specific practice (RTP) - Stroke, Hemispatial Neglect
Phase 1TerminatedMedical University of South Carolina12016-07-012021-09-13

Narrower conditions

Agnosia (7)  ·  Pain, Postoperative (4)  ·  Paresis (1)  ·  Stroke (1)

Broader conditions

Nervous System Diseases (8)  ·  Neurobehavioral Manifestations (8)  ·  Neurologic Manifestations (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Signs and Symptoms (8)  ·  Pain (4)  ·  Pathologic Processes (4)  ·  Postoperative Complications (4)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Vascular Diseases (1)

Interventions

Oxycodone (3)  ·  Acetaminophen (2)  ·  Epinephrine (2)  ·  Ibuprofen (2)  ·  Anesthetics, Local (1)  ·  Buprenorphine (1)  ·  Lidocaine (1)  ·  Transcranial Direct Current Stimulation (1)  ·  Triiodothyronine (1)  ·  neosaxitoxin (1)

Sponsors

David Chi, MD (2)  ·  GrĂ¼nenthal GmbH (1)  ·  Kalyra Pharmaceuticals, Inc. (1)  ·  Medical University of South Carolina (1)  ·  Nordsjaellands Hospital (1)  ·  Overseas Pharmaceuticals, Ltd. (1)  ·  University Hospitals Cleveland Medical Center (1)

Countries

United States (5)  ·  Denmark (1)  ·  Netherlands (1)  ·  Taiwan (1)

Top investigators

David H Chi, MD (2)  ·  Emily Grattan, PhD, OTR/L (1)  ·  Kevin Bunker, PhD (1)  ·  Mikkel H. Madsen, MD (1)

Results publications

PMID 29570501, PMID 40396501

NIH funding

2016 (1), P2CHD086844 (1)